Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid. (Q51792971)

12 April 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid. (English)

1 reference

12 April 2018

author name string

Jun Iwamoto

1

1 reference

12 April 2018

Azusa Seki

2

1 reference

12 April 2018

Tsuyoshi Takeda

3

1 reference

12 April 2018

Yoshihiro Sato

4

1 reference

12 April 2018

Harumoto Yamada

5

1 reference

12 April 2018

Chwan-Li Shen

6

1 reference

12 April 2018

James K Yeh

7

1 reference

12 April 2018

publication date

1 July 2006

1 reference

12 April 2018

published in

Experimental Animals

1 reference

12 April 2018

volume

55

1 reference

12 April 2018

issue

4

1 reference

12 April 2018

page(s)

349-355

1 reference

12 April 2018

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

New developments in the pathogenesis and treatment of steroid-induced osteoporosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

The Comparative Efficacy of Drug Therapies Used for the Management of Corticosteroid-Induced Osteoporosis: A Meta-Regression

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Bisphosphonates for steroid induced osteoporosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Use of oral corticosteroids and risk of fractures.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1538/EXPANIM.55.349

Identifiers

DOI

10.1538/EXPANIM.55.349

1 reference

12 April 2018

1 reference

12 April 2018